Skip to content

T.DIFFUSION

Active Public limited companyfounded 1977active for 48 yearsAvenue Thomas Edison 32, 1402 NivellesKBO/BCE: BE 0418.157.102 subsidiary of Trenker HoldCo#3 company by total assets in Nivelles, Health and social work sector

Overview

Lifetime

20 annual accounts with figures on one time axis, 48 filings since 1978
Gross marginpeak €3.1m (2013)
€1.0m▼ 18.3%
Resultlowest -€1.1m (2017)
€141,001▼ 51.3%
Equitypeak €1.3m (2025)
€1.3m▲ 49.7%
Debts
€10.4m▼ 5.4%
Staffpeak 43.7 FTE (2012)
-not published
Board7 names since 2015
3 directorsERUDITE and 2 others
Owners2 names in the annual accounts
100%Trenker HoldCo
Documentsfilings and deeds
30-06-202631 days before the deadline
2025financial year
Gross margin from €1.3m to €1.0mResult from €289,496 to €141,001Registered office moved from Schaerbeek to Thines 01-09Equity from €835,804 to €1.3mCash from €92,079 to €48,758

Key points

from the 2025 annual accounts

Equity

€1.3m ▲ 49.7%

T.DIFFUSION has made a profit without a break since 2020.

Result

€141,001 ▼ 51.3%
€289,0002024€141,0002025

The result fell in 2025 from €289,496 to €141,001.

Debts

€10.4m 89% of the balance sheet
Financial debts 89%Suppliers 3%Taxes and wages 0%Other 8%

Of this, €1.1m falls due within a year.

Liquidity

0.84 was 0.29 in 2024

Short-term debts rose from €850,650 to €1.1m.

Filings

48 annual accounts since 1978
AprilJune31 JulyOctober1980199520102025

Six of the last ten came late. The 2017 accounts came latest: 70 days after the end of the period.

Position in the sector

10.7%

Lower solvency than 84% of companies in human health. Sector median 58.0% · 783 companies.

Checked score

89
Excellent
Financially stronger than 43% of medium-sized companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 84 companies (NACE 86, medium-sized).

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.2 percentage points vs 08-2025lowest value 10-2025: 0.1%▲ +0.1 percentage points vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.2%▲ +0.1 percentage points vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026 11-2026: 0.2%● unchanged vs 10-2026

Financial strength
Weak

Solvency
36+4equity 10.7% of total assets
Liquidity
51=short-term debt 9.3% · cash 0.4%
Profitability
40-14return on assets 1.2%

Score breakdown

raises risk
Liquidity: current ratio 0.84, cash €48,758
1 change of registered office in 24 months
lowers risk
Size: total assets €11.7m
Sector: Human health activities (NACE 86)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, medium-sized). It does better than 14% of them on solvency, 44% on liquidity, 23% on profitability and 94% on growth.

The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit verdict

Credit of up to €110,000 on 30-day terms is acceptable

Liquidity is insufficient, with a current ratio of 0.84 (0.29 in 2024), below 1. Short-term debt is 9.3% and cash 0.4% of total assets. 89.3% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Seven signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 0.84, cash €48,758
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Size: total assets €11.7m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 783 sector peers (2025).
NBB · sector comparison
Position among 783 sector peers
Solvency
better than 16%
← weakest strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €1.3m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2024
1 day late
2023
41 days early
2022
41 days early
2021
3 days late
2020
20 days late
2019
42 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 7 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 June (4 of the last 5 accounts filed within 32 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

E
Director, Louis Declerck, since 27-06-2024
F
Director, Barbara De Saedeleer, since 27-06-2024
M
Director, Charles Declerck, since 27-06-2024
  • Trenker HoldCo 100%equity €22.7m (2025) · 2025 annual accounts of Trenker HoldCo
  • ROBINWOOD 98.57%score 57equity €12.0m (2024) · 2024 annual accounts of ROBINWOOD
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0418157102
Registered office moved from Schaerbeek to Thines New registered office: Avenue Thomas Edison 32, 1402 Thines · Previous registered office: Avenue Rogier 228, 1030 Schaerbeek · Registered office clause: Avenue Thomas Edison 32, 1402 Thines · General meeting of 18-08-2025 · Gazette deed
3 directors appointed, 3 resignations Resignations: Robinwood SA (daily management delegate), Pascale Trenker and Daniel Catoul · Appointments: Erudite BV, Medeca BV and Foxfin BV · Permanent representatives: Rodolphe Trenker, Louis Declerck, Charles Declerck and Barbara De Saedeleer · General meeting of 27-06-2024 · Gazette deed
Resignation: Rodolphe Trenker (director) Appointment: Daniel Catoul (director) · General meeting of 04-10-2021 · Gazette deed
All 60 events

Comparable companies

same main activity, similar in size and age
Company Total assets Gross margin Solvency Staff
T.DIFFUSION Nivelles €11.7m €1.0m 10.7% -
Vlaamse Vereniging voor Respiratoire Gezondheidszorg en Tuberculosebestrijding Leuven €8.0m €2.5m 81.4% 26.4
LA RESIDENCE LE PIC - AU - VENT Tournai €11.8m €3.2m 11.1% 39.6
AGENCE EUROPEENNE POUR LE DEVELOPPEMENT ET LA SANTE Brussels €3.9m €1.0m 39.1% 6.5
Permanence Soins àDomicile Namur €9.3m €3.5m 85.5% 34.4
ORTHEVAL Rixensart €3.3m €0.7m 76.8% -
Allucent (Belgium) Scherpenheuvel-Zichem €11.8m €0.5m 9.7% -

These companies have the same main activity as T.DIFFUSION: nutrition and dietetics services (NACE 86995). They are comparable in size and age: total assets between €3.3m and €12m, founded between 1981 and 2004.

Official details

Source: KBO
Status
Active since 19-12-1977Normal situation
Activity
Nutrition and dietetics servicesNACE 86995
Establishment unit
2.014.893.8961402 Nivelles, since 01-01-1978
Financial year end
31 December
Peppol
Reachable since 02-06-2026
Company details

Annual accounts 2025

Gross margin
€1.0m▼ 18.3%
Turnover
≈ €900,000estimated
Profit
€141,001▼ 51.3%
Equity
€1.3m▲ 49.7%
Total assets
€11.7m▼ 1.5%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Companies linked to T.DIFFUSION

Insights on T.DIFFUSION

T.DIFFUSION has existed since 1977. The present size dates from 2018. The gross margin rose that year from €204,259 to €1.0m.

Trenker HoldCo holds all the shares. In July 2024, three directors stepped down.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

full format, filed on 30-06-2026, 31 days before the deadline
Gross margin
€1.0m
▼ 18.3%
Operating result
€146,538
▼ 58.3%
Profit
€141,001
▼ 51.3%
Working capital
-€170,394
▲ €435,643
Solvency
10.7%
▲ 3.7 percentage points
Current ratio
0.84
▲ 0.56

The turnover shown is an estimate from the gross margin.

Turnover ≈ €900,000. Estimated: probably between €820,000 and €1.3m.

Balance sheet

balance sheet total €11.7m on 31-12-2025
What the company ownsHow it is paid for

Change in equityin €m

Change in cashin €m

Position in the sector

Solvency10.7%

Higher than 16% of 783 companies in 2025.

Current ratio0.84

Higher than 15% of 770 companies in 2025.

Return on assets1.2%

Higher than 24% of 775 companies in 2025.

T.DIFFUSION Middle half of the sector 80% of the sector Full accounts in human health (NACE 86)

Net result: middle half · Equity: middle half · Balance sheet total: top quarter · Working capital: bottom quarter

Staff

Staff cost per FTE

Staff costs divided by the average number of full-time equivalents.

Joined and left

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015201420132012201120102009200820072006
Balance sheet: assets
Total assets20/58 11.7m11.9m5.6m6.1m6.6m7.9m8.7m10.4m11.2m3.7m1.9m1.8m1.9m1.9m1.8m1.3m1.5m1.5m1.6m1.7m
Fixed assets21/28 10.8m11.6m5.6m5.7m6.5m7.6m8.5m9.5m10.0m3.7m486,100551,120631,052708,768765,498810,9091.1m1.0m1.2m1.3m
Tangible fixed assets22/27 3.1m3.9m4.8m5.7m6.5m7.5m8.4m9.5m9.9m3.6m486,100548,336611,800673,969715,967747,182794,462847,814901,164969,398
Land and buildings22 3.1m3.9m4.8m5.7m6.5m7.5m8.4m9.5m9.9m958,330477,711531,061584,411637,762691,112741,112794,462847,814901,164954,514
Plant, machinery and equipment23 -----------4,53810,59316,64922,7046,070----
Furniture and vehicles24 ----------8,38912,73716,79619,5582,151----14,884
Assets under construction and advance payments27 ---24,332---34,000-2.7m----------
Financial fixed assets28 7.7m7.7m780,000-26,70026,70026,70026,70026,70026,700-2,78419,25234,79949,53163,727262,228162,618257,854284,306
Current assets29/58 911,984244,61351,201403,18992,600390,329208,393852,9191.2m10,1451.4m1.3m1.3m1.2m1.0m526,919431,734500,720455,284430,512
Amounts receivable after more than one year29 ----------250,000275,000300,000300,000300,000--48,00048,00048,000
Other amounts receivable291 ----------250,000275,000300,000300,000300,000--48,00048,00048,000
Amounts receivable within one year40/41 3,7421193162,8465069,4772,868567,2391.1m9,6691.1m910,983941,957872,961680,627489,354230,316403,714276,343334,039
Trade receivables40 --------2,0697941.0m859,231924,930799,910596,895462,810160,314317,013179,996272,206
Other amounts receivable41 3,7421193162,8465069,4772,868567,2391.1m8,87545,40051,75217,02773,05183,73226,54470,00286,70196,34761,833
Cash at bank and in hand54/58 48,75892,07937,940340,34392,550120,8525,52585,68077,04247634,66865,97715,99219,56624,83237,565181,75849,006107,68221,975
Deferred charges and accrued income490/1 859,484152,52312,330--200,000200,000200,000--1,086-1661,460--19,660-23,25926,498
Balance sheet: equity and liabilities
Total equity and liabilities10/49 11.7m11.9m5.6m6.1m6.6m7.9m8.7m10.4m11.2m3.7m1.9m1.8m1.9m1.9m1.8m1.3m1.5m1.5m1.6m1.7m
Equity10/15 1.3m835,804658,819438,533550,712-492,962-452,869-85,978272,280346,923633,026632,474632,424601,079521,527519,830463,070437,984503,733489,255
Contributions10/11 207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944
Capital10 207,944207,944207,944207,944207,944---------------
Issued capital100 207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944207,944
Revaluation surpluses12 -----400,000400,000400,000400,000400,000400,0001.0m1.0m1.0m1.0m1.0m1.0m1.0m1.0m1.0m
Reserves13 532,597532,597532,597532,597532,597532,597532,597532,597532,597532,597620,79520,79520,79520,79520,79519,40012,00010,50010,5009,700
Non-distributable reserves130/1 20,79520,79520,79520,79520,79520,795--------------
Legal reserve130 20,79520,79520,79520,79520,79520,79520,79520,79520,79520,79520,79520,79520,79520,79520,79519,40012,00010,50010,5009,700
Distributable reserves133 511,802511,802511,802511,802511,802511,802511,802511,802511,802511,802600,000---------
Profit (loss) carried forward14 -24,176-165,177-454,673-787,470-787,802-2.3m-2.4m-2.2m-1.9m-793,618-595,713-596,265-596,315-627,660-707,212-707,514-756,874-780,460-714,711-728,389
Investment grants15 534,560260,440372,951485,462597,973710,484822,995935,5061.0m-----------
Provisions and deferred taxes16 -----------------18,67418,67418,674
Provisions for liabilities and charges160/5 -----------------18,67418,67418,674
Amounts payable17/49 10.4m11.0m5.0m5.6m6.0m8.4m9.1m10.5m10.9m3.3m1.2m1.2m1.3m1.3m1.2m817,9981.0m1.1m1.1m1.2m
Amounts payable after more than one year17 9.3m10.1m4.5m4.9m5.4m5.8m6.3m7.0m7.0m1.6m--8,2428,2428,2428,242380,083380,083393,610472,154
Financial debts170/4 9.3m10.1m4.5m4.9m5.4m5.8m6.0m6.4m7.0m1.6m----------
Other amounts payable178/9 ------286,000572,000----8,2428,2428,2428,242380,083380,083393,610472,154
Amounts payable within one year42/48 1.1m850,650472,008470,086642,3022.6m2.8m3.4m3.9m1.7m1.2m1.2m1.2m1.3m1.2m809,756645,271674,411697,471698,975
Current portion of amounts payable after more than one year42 746,667746,667445,664436,888428,155419,596415,200407,074-----------14,171
Financial debts43 -25,356---1.7m2.0m2.7m3.1m606,396469,811509,767537,080549,735504,122156,354174,095192,618250,672236,542
Credit institutions430/8 -25,356---1.7m2.0m2.7m3.1m606,396469,811509,767537,080549,735504,122156,354174,095192,618250,672236,542
Trade debts44 304,2121,6801,65033,1981,5009,93531,15840,054391,9991.0m120,913108,713125,183136,060143,876105,73597,915127,91087,96586,530
Suppliers440/4 304,2121,6801,65033,1981,5009,93531,15840,054391,9991.0m120,913108,713125,183136,060143,876105,73597,915127,91087,96586,530
Taxes, remuneration and social security45 21,49946,19324,694-26,647-----573,480552,126538,238558,637507,812456,665372,259352,880358,207361,105
Taxes450/3 21,49946,19324,694-26,647-----187,972179,793154,972161,125139,435167,859103,912106,839117,100111,925
Remuneration and social security454/9 ----------385,508372,333383,266397,512368,377288,806268,347246,041241,107249,180
Other amounts payable47/48 10,00030,754--186,000486,000382,000311,630437,00018,00055,000-48,00049,00285,00291,0021,0021,003627627
Accrued charges and deferred income492/3 29,436113,415-240,00013,61023,445-25,629------376---8145,158
Income statement
Non-recurring operating income76A ----1.3m33,117-2,180-------2,43536,80519,50050,590-
Gross operating margin9900 1.0m1.3m1.2m1.1m2.5m1.1m971,7761.0m204,259-4,7172.9m3.0m3.1m3.1m2.7m2.4m2.1m2.1m1.9m1.9m
Remuneration, social security and pensions62 ----------2.8m2.9m2.9m2.8m2.5m2.1m2.0m2.0m1.8m1.8m
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 874,464871,636871,636869,773858,685912,6191.2m1.1m1.1m124,79065,11566,64065,87164,94556,77254,86853,35053,35068,23468,234
Provisions for liabilities and charges: additions (uses and reversals)635/8 -----------------18,674--18,674
Other operating charges640/8 10027,582--1,11816,00715,7818471-1,590895541628057887925,84432,4541,258
Non-recurring operating charges66A ---240,000----188,354-50-123-5037015079,112-876
Operating profit (loss)9901 146,538351,198338,2112,0581.6m132,912-207,371-123,147-1.1m-129,50749,48329,068129,642203,319130,193206,38862,30369,97324,27292,528
Financial income75/76B 482,617354,038124,841112,511112,530112,511112,511112,51181,9842,0408,66513,51112,47116,0098,2103,0298,94813,4778,03011,930
Recurring financial income75 482,617354,038124,841112,511112,530112,511112,511112,51181,9842,0408,66513,51112,47116,0098,2103,0298,94813,4778,03011,930
Financial charges65/66B 439,895319,241105,561114,237142,046173,005159,520235,112143,31670,4388,48714,95013,63317,03310,4926,2129,75517,73917,43217,903
Recurring financial charges65 439,895319,241105,561114,237142,046173,005159,520235,112143,31670,4388,48714,95013,63317,03310,4926,2129,75517,73917,43217,903
Profit (loss) for the period before taxes9903 189,260385,995357,4913321.6m72,418-254,380-245,748-1.1m-197,90549,61127,629128,357202,295127,861205,27098,1516,09965,46085,679
Income taxes67/77 48,25996,49924,694-26,647-----49,05927,57949,01274,74342,16458,51073,06571,84850,98262,380
Profit (loss) for the period9904 141,001289,496332,7973321.6m72,418-254,380-245,748-1.1m-197,9055525079,345127,55285,697146,76025,086-65,74914,47823,299
Profit (loss) for the period to be appropriated9905 141,001289,496332,7973321.6m72,418-254,380-245,748-1.1m-197,9055525079,345127,55285,697146,76025,086-65,74914,47823,299
Appropriation of the result
Profit (loss) to be appropriated9906 -24,176-165,177-454,673-787,470-787,802-2.3m-2.4m-2.2m-1.9m-793,618-595,713-596,265-548,315-579,660-621,817-610,114-755,374-780,460-713,911-727,189
Profit (loss) brought forward from the previous period14P -165,177-454,673-787,470-787,802-2.3m---------------
Transfer to equity691/2 --------------1,3957,4001,500-8001,200
To the legal reserve6920 --------------1,3957,4001,500-8001,200
Profit to be distributed694/7 ------------48,00048,00084,00090,000----
Directors or managers695 ------------48,00048,00084,00090,000----
Social balance sheet
Average staff (FTE)9087 ----------38.839.341.643.742.133.231.331.530.629.8
Hours worked1013 ----------59,06262,06864,81965,73264,38650,50448,68349,91248,61546,466
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The accounts for 28 older financial years (1978-2005) were filed as documents without figures as data, scans for example.

The notes to these accounts have 9 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 30-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 full format 30-06-2026 2026-00243892 PDF
31-12-2024 full format 01-08-2025 2025-00347776 PDF
31-12-2023 full format 20-06-2024 2024-00144779 PDF
31-12-2022 full format 20-06-2023 2023-00142389 PDF
31-12-2021 full format 03-08-2022 2022-20265677 PDF
31-12-2020 full format 20-08-2021 2021-51900547 PDF
31-12-2019 full format 11-09-2020 2020-52800356 PDF
31-12-2018 full format 15-07-2019 2019-33400394 PDF
31-12-2017 full format 09-10-2018 2018-69000385 PDF
31-12-2016 full format 03-10-2017 2017-66000482 PDF
31-12-2015 full format 19-07-2016 2016-33400430 PDF
31-12-2014 full format 04-01-2016 2016-00200092 PDF
31-12-2013 full format 16-09-2014 2014-58700353 PDF
31-12-2012 full format 17-10-2013 2013-63300151 PDF
31-12-2011 full format 17-10-2012 2012-61100496 PDF
31-12-2010 full format 23-11-2011 2011-61600298 PDF
31-12-2009 full format 31-08-2010 2010-50200258 PDF
31-12-2008 full format 25-11-2009 2009-86400056 PDF
31-12-2007 full format 19-02-2009 2009-05300007 PDF
31-12-2006 full format 28-12-2007 2007-85300278 PDF
31-12-2005 full format 26-10-2006 2006-85004398 PDF
31-12-2004 full format 09-03-2006 2006-06804448 PDF
31-12-2003 full format 18-01-2005 2005-02001893 PDF
31-12-2002 full format 29-01-2004 2004-03003003 PDF
31-12-2001 full format 18-11-2002 2002-72103510 PDF
31-12-2000 full format 05-04-2002 2002-09000804 PDF
31-12-1999 full format 11-10-2000 2000-63804357 PDF
31-12-1998 full format 08-12-1999 1999-62300821 PDF
31-12-1997 full format 18-11-1998 1998-57903331 PDF
31-12-1996 full format 19-01-1998 1998-01300080 PDF
31-12-1995 full format 30-07-1996 1996-38102345 PDF
31-12-1994 full format 28-08-1995 1995-46901633 PDF
31-12-1993 full format 12-09-1994 1994-39300574 PDF
31-12-1992 full format 06-12-1993 1993-44902964 PDF
31-12-1991 full format 14-12-1992 1992-40501784 PDF
31-12-1990 full format 22-01-1992 1992-00904382 PDF
31-12-1989 full format 09-11-1990 1990-27500670 PDF
31-12-1988 full format 19-02-1990 1990-01300925 PDF
31-12-1987 full format 03-10-1988 1988-21403642 PDF
31-12-1986 full format 07-07-1987 1987-16002216 PDF
31-12-1985 full format 18-08-1986 1986-35301747 PDF
31-12-1984 full format 02-07-1985 1985-19401191 PDF
31-12-1983 unclassified schema 12-07-1984 1984-10002054 PDF
31-12-1982 unclassified schema 15-07-1983 1983-09701070 PDF
31-12-1981 unclassified schema 16-07-1982 1982-09402303 PDF
31-12-1980 unclassified schema 28-07-1981 1981-09800443 PDF
31-12-1979 unclassified schema 23-07-1980 1980-09600851 PDF
31-12-1978 unclassified schema 27-07-1979 1979-09601009 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015201420132012201120102009200820072006
EBITDA 1.0m1.2m1.2m871,8312.5m1.0m955,9951.0m15,834-4,717114,59895,708195,513268,264186,965261,256115,653123,32392,506160,762
Cash flow 1.0m1.2m1.2m870,1052.4m985,037908,986902,841-45,498-73,11565,66766,690145,216192,497142,469201,62878,436-12,39982,71291,533
Investment in fixed assets (approximation) 26,3676.9m784,50090,991-210,9594,261147,772685,6647.4m3.3m2,8793,1763,70223,14525,5577,58675,0004504,11514
Change in cash -43,32154,139-302,403247,793-28,302115,327-80,1558,63876,566-34,192-31,30949,985-3,574-5,266-12,733-144,193132,752-58,67685,707-
Working capital -170,394-606,037-420,807-66,897-549,702-2.2m-2.6m-2.6m-2.7m-1.7m146,92681,3549,614-99,447-235,353-282,837-213,537-173,691-242,187-268,463
Solvency 10.7%7.0%11.7%7.2%8.4%-6.2%-5.2%-0.8%2.4%9.5%34.2%35.1%33.5%31.6%29.4%38.9%31.1%29.0%31.2%29.0%
Current ratio 0.840.290.110.860.140.150.070.250.310.011.121.071.010.920.810.650.670.740.650.62
Debt to equity 8.3513.217.5312.8710.95---40.139.551.931.851.992.172.401.572.212.412.172.40
ROE 11.3%34.6%50.5%0.1%282.6%----412.3%-57.0%0.1%0.0%12.5%21.2%16.4%28.2%5.4%-15.0%2.9%4.8%
ROA 1.2%2.4%5.9%0.0%23.7%0.9%-2.9%-2.4%-10.0%-5.4%0.0%0.0%4.2%6.7%4.8%11.0%1.7%-4.4%0.9%1.4%
Interest coverage 2.323.8311.467.6317.40---------------

EBIT margin: not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€26,367-€4,500€90,991-
Financial fixed assets-€6.9m€780,000--
Depreciation and write-downs of the year€874,464€871,636€871,636€869,773€858,685

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on T.DIFFUSION

The operating result for 2025 is 58% lower than in 2024 and the lowest since 2022.

Debt's share of the balance-sheet total falls from 93.0% to 89.3%. Equity is higher and debt is lower.

Large changes and their cause
  • 2022 Net result -100% on 2021. The 2021 profit included a one-off income of €1,302,807.
  • 2021 Net result +2,049% on 2020. The 2021 profit included a one-off income of €1,302,807.

Board & ownership

Board

3 directors, last change in 2024
Director, permanent representative Louis Declerck
since 27-06-2024 term until 26-06-2030
also on the board of 5 other companies
listed in the 2025 annual accounts, filed on 30-06-2026
Director, permanent representative Barbara De Saedeleer
since 27-06-2024 term until 26-06-2030
also on the board of 6 other companies
listed in the 2025 annual accounts, filed on 30-06-2026
Director, permanent representative Charles Declerck
since 27-06-2024 term until 26-06-2030
also on the board of 5 other companies
listed in the 2025 annual accounts, filed on 30-06-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Le conseil d’administration et les délégués à la gestion journalière, ces derniers dans la limite de ladite gestion, pourront conférer des…”
deed of 01-09-2025
Permanent representatives 3
Barbara De Saedeleer
Permanent representative, for Foxfin
appointed by deed of 29-07-2024
Charles Declerck
Permanent representative, for Medeca
appointed by deed of 29-07-2024
Louis Declerck
Permanent representative, for ERUDITE
appointed by deed of 29-07-2024

Office holders in the KBO →

Mandates through the years

7 names, the dashed line is today
ERUDITE
Director
Foxfin
Director
Medeca
Director
Robinwood SA
Daily management delegate
BoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
  • ERUDITE
    • Director, from 27-06-2024 to date
  • Foxfin
    • Director, from 27-06-2024 to date
  • Medeca
    • Director, from 27-06-2024 to date
  • Daniel Catoul
    • Director, from 01-10-2021 to 29-07-2024
  • Pascale Trenker
    • Director, from 15-12-2018 to 29-07-2024
  • Robinwood SA
    • Director, from 15-12-2015 to 29-07-2024
    • Daily management delegate, until 29-07-2024
  • Rodolphe Trenker
    • Director, until 25-10-2021

See the board, name and registered office on a given date →

Control

Parent
Equity €22.7m
Loss €2.9m in 2025
100%
This company
T.DIFFUSION
Equity €1.3m
Profit €141,001 in 2025

Further up the chainErudite Corporate 86.3%Erudite.Health 100%

and 1 other shareholder

Capital

Capital
€207,944
Shares
280
Contribution per share
€743
Equity per share
€4,468 in 2025
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
98.57% until 2024
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

deed of 01-09-2025 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Daily managementDay-to-day management handles the everyday running of the business without the full board.
The delegates act alone or jointly
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 3 directors
Term of at most 6 years
“Le conseil d’administration peut constituer en son sein et sous sa responsabilité un ou plusieurs comités consultatifs, il définit leur…”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Thursday of June at 17:30

Shareholders

2 owners

Owners 2

Network & group

Group

Trenker HoldCo has 2 direct subsidiaries (2025 accounts), the bar shows equity in euros
ParentTrenker HoldCo2 holdings, 1 country 2025 accounts

Belgium 2 Equity Result

Source: list of holdings in the 2025 accounts of Trenker HoldCo. Every holding stands with its own latest accounts.

At the same address

Avenue Thomas Edison 32, 1402 Nivelles · 4 other companies
N.V. Farmaceutische Laboratoria Trenker
registered office since 14-06-2017 · founded in 1983
88 FTE (2025)
0423.960.076
ROBINWOOD
establishment since 08-09-1993 · founded in 1993 · accounts filed late
total assets €16.4m (2024)
0449.595.196
TRENKER NUTRITION
registered office since 19-01-2018 · founded in 2018
total assets €72,988 (2025)
0688.640.216
Unité TRENKER
registered office since 01-05-2016
founded in 2016
0654.908.960

Earlier ties

ALYCHLO
via Foxfin, no longer at ALYCHLO · Director · deed of 07-05-2015
founded in 2008
total assets €1.20bn (2025)

Connections & network

11 connected companies
Linked via shared directors
BEAULIEU INTERNATIONAL GROUP
via Foxfin · Bestuurder buiten aandelencategorie (extern bestuurder) · deed of 11-10-2019
Founded in 1990 · 163 FTE (2025)
→
KOLMONT HOLDING
via Foxfin · Class C director · deed of 19-09-2024
Founded in 2016 · turnover €3.4m (2025)
→
Erudite.Health
via ERUDITE, Medeca and Foxfin · deeds of 21-05-2026 and 05-12-2025
Founded in 2022 · total assets €29.2m (2025)
→
S.A. Laboratoires Pharmaceutiques Trenker
via ERUDITE, Medeca and Foxfin · deeds of 17-09-2026 and 05-08-2024
Founded in 1983 · 88 FTE (2025)
→
Show 7 more companies with a shared director
Erudite Corporate
via ERUDITE and Medeca · Gewone/niet statutair bestuurder · deed of 25-06-2024
Founded in 2024 · total assets €22.0m (2025)
→
ORSI ACADEMY
via Foxfin · Director · deed of 26-08-2025
Founded in 2015 · 6.9 FTE (2025)
→
NUTRIPHYT
via ERUDITE and Medeca (no longer at NUTRIPHYT) · deeds of 29-01-2025 and 17-11-2023
Founded in 2002 · 22 FTE (2025)
→
TRENKER NUTRITION
via ERUDITE, Medeca and Foxfin · Director · deed of 29-07-2024
Founded in 2018 · total assets €72,988 (2025)
→
ERUDITE.HEALTH GLOBAL
via ERUDITE and Medeca · Director (not named in the articles) · deed of 24-12-2025
Founded in 2025
→
ERUDITE.HEALTH SPECTRUM
via ERUDITE and Medeca · Director · deed of 24-12-2025
Founded in 2025
→
Offtrack wheels
via Foxfin · Director (not named in the articles) · deed of 30-01-2026
Founded in 2025
→

Timeline

Timeline

60 events since 1977

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBfull format · 31 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0418157102
2025
Equity above €1m equity €1.3m ▲49.7% After 6 profitable years in a row, equity reaches €1.3m.
Registered office moved from Schaerbeek to ThinesNew registered office: Avenue Thomas Edison 32, 1402 Thines · Previous registered office: Avenue Rogier 228, 1030 Schaerbeek · Registered office clause: Avenue Thomas Edison 32, 1402 Thines · General meeting of 18-08-20254 points ▸
  • General meeting, 18-08-2025
  • Registered-office move, Avenue Thomas Edison 32, 1402 Thines
  • Capital, €207,943.59, 280 shares
  • Registered office clause, Avenue Thomas Edison 32, 1402 Thines
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2024 filed PDFfull format · 1 day late
2024
3 directors appointed, 3 resignationsResignations: Robinwood SA (daily management delegate), Pascale Trenker and Daniel Catoul · Appointments: Erudite BV, Medeca BV and Foxfin BV · Permanent representatives: Rodolphe Trenker, Louis Declerck, Charles Declerck and Barbara De Saedeleer · General meeting of 27-06-202413 points ▸
  • General meeting, 27-06-2024
  • Director resignation, Robinwood SA
  • Director resignation, Pascale Trenker
  • Director resignation, Daniel Catoul
  • Director appointment, Erudite BV
  • Director appointment, Medeca BV
  • Director appointment, Foxfin BV
  • Permanent representative, Rodolphe Trenker
  • Permanent representative, Louis Declerck
  • Permanent representative, Charles Declerck
  • Permanent representative, Barbara De Saedeleer
  • Board meeting, 27-06-2024
  • Director resignation, Robinwood SA (daily management delegate)

Open the deed in the Belgian Official Gazette

Annual accounts 2023 filed PDFfull format · 41 days before the deadline
2023
Annual accounts 2022 filed PDFfull format · 41 days before the deadline
2022
Annual accounts 2021 filed PDFfull format · 3 days late
2021
Highest result from 2006 to 2025 net €1.6m ▲2,049% The operating result of €1.6m and the net result of €1.6m are both a record.
Resignation: Rodolphe Trenker (director)Appointment: Daniel Catoul (director) · General meeting of 04-10-20213 points ▸
  • General meeting, 04-10-2021
  • Director resignation, Rodolphe Trenker
  • Director appointment, Daniel Catoul

Open the deed in the Belgian Official Gazette

Annual accounts 2020 filed PDFfull format · 20 days late
2020
Back to profit net €72,418 The net result is €72,418, after 4 loss-making years.
Annual accounts 2019 filed PDFfull format · 42 days late
2019
Annual accounts 2018 filed PDFfull format · 16 days before the deadline
2018
Annual accounts 2017 filed PDFfull format · 70 days late
2017
Weakest financial year net -€1.1m The net result drops to -€1.1m, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2016 filed PDFfull format · 64 days late
2016
Annual accounts 2015 filed PDFfull format · 12 days before the deadline
Annual accounts 2014 filed PDFfull format · 157 days late
2014
Annual accounts 2013 filed PDFfull format · 47 days late
2013
Annual accounts 2012 filed PDFfull format · 78 days late
2012
Annual accounts 2011 filed PDFfull format · 78 days late
2011
Annual accounts 2010 filed PDFfull format · 115 days late
2010
Annual accounts 2009 filed PDFfull format · 31 days late
2009
Back to profit net €25,086 The net result is €25,086, after one loss-making year.
Annual accounts 2008 filed PDFfull format · 117 days late
Annual accounts 2007 filed PDFfull format · 203 days late
2007
Equity above €500,000 equity €503,733 ▲3% With a profit in every financial year since 2006, equity grows to €503,733.
Annual accounts 2006 filed PDFfull format · 150 days late
2006
Annual accounts 2005 filed PDFfull format
Annual accounts 2004 filed PDFfull format
2005
Annual accounts 2003 filed PDFfull format
2004
Annual accounts 2002 filed PDFfull format
2002
Annual accounts 2001 filed PDFfull format
Annual accounts 2000 filed PDFfull format
2000
Annual accounts 1999 filed PDFfull format
1999
Annual accounts 1998 filed PDFfull format
1998
Annual accounts 1997 filed PDFfull format
Annual accounts 1996 filed PDFfull format
1996
Annual accounts 1995 filed PDFfull format
1995
Annual accounts 1994 filed PDFfull format
1994
Annual accounts 1993 filed PDFfull format
1993
Annual accounts 1992 filed PDFfull format
1992
Annual accounts 1991 filed PDFfull format
Annual accounts 1990 filed PDFfull format
1990
Annual accounts 1989 filed PDFfull format
Annual accounts 1988 filed PDFfull format
1988
Annual accounts 1987 filed PDFfull format
1987
Annual accounts 1986 filed PDFfull format
1986
Annual accounts 1985 filed PDFfull format
1985
Annual accounts 1984 filed PDFfull format
1984
Annual accounts 1983 filed PDFunclassified schema
1983
Annual accounts 1982 filed PDFunclassified schema
1982
Annual accounts 1981 filed PDFunclassified schema
1981
Annual accounts 1980 filed PDFunclassified schema
1980
Annual accounts 1979 filed PDFunclassified schema
1979
Annual accounts 1978 filed PDFunclassified schema
1978
First establishment T-DIFFUSION, Avenue Thomas Edison 32, Nivelles
1977
Incorporation KBO

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

T.DIFFUSION was incorporated on 19 December 1977.1 The registered office was moved to Thines in 2025.2 Total assets rose from €10.4m in 2018 to €11.7m in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 01-09-2025
  3. 3National Bank, annual accounts 2018 and 2025

Company details

Identity

Enterprise number
0418.157.102
VAT number
BE 0418.157.102
Peppol ID
0208:0418157102
Other Peppol ID
9925:BE0418157102
LEI code
529900DMP06CKZE9HF41 live in the LEI register
Legal form
Public limited company
Status
Active, normal situation
Founded
19-12-1977
Financial year
ends on 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Thursday of June at 17:30
deed of 01-09-2025 (in French)
Peppol
Reachable since 02-06-2026Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
T.DIFFUSION in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 01-09-2025 (in French)

Activities

NACEBEL 2025
86995 Nutrition and dietetics services main activity
Codes under NACEBEL 2008
86909 Human health activities main activity
Codes under NACEBEL 2003
85143 main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
“Construire ou faire construire des bâtiments en vue de les conserver ou de les céder, en tout ou en partie, à titre onéreux; Réaliser toutes…”
5 activities
  1. Construire ou faire construire des bâtiments en vue de les conserver ou de les céder, en tout ou en partie, à titre onéreux
  2. Réaliser toutes prestations relatives à la fourniture d’informations spécifiques au domaine médical et pharmaceutiques, ainsi qu'à la formation de la sélection du personnel pour toutes activités, notamment dans le domaine médical, paramédical et pharmaceutique, ainsi que l’information et la publicité en matière médicale et pharmaceutique
  3. Intervenir en tant qu’intermédiaire dans toutes les transactions commerciales généralement quelconques
  4. Acheter, vendre, fabriquer, importer et exporter tout produit généralement quelconque
  5. Rendre toutes services dans quelque domaine que ce soit, à l’exception des domaines qui, par une disposition légale sont réservés en exclusivité à des personnes ayant des qualifications spécifiques que la société n’aurait pas
deed of 01-09-2025 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
T-DIFFUSION registered office Avenue Thomas Edison 32, 1402 Nivelles 68201 Renting and operating of own or leased residential real estate, excluding social housing 01-01-1978 2.014.893.896
1 former office
  • 1030 Schaerbeek until the deed of 01-09-2025

Buildings and parcels at the address

Ground area
9,952 m²
Buildings
3,087 m²
Volume, LiDAR
36,332 m³
Tallest building
13.2 m
Buildings to scale, each on its own parcel
3,087 m², 13.2 m 3,087 m², 13.2 m

Location

registered office establishment The establishment unit on the map
5 companies at this address See who is registered here

Parcels

Cadastral parcelArea Buildings Height / floors
25099D0044/00F0009,952 m² 1 · 3,087 m² 13.2 m · 4